Effect of levofloxacin on serum glucose concentration in rats

European Journal of Pharmacology

Volumn 551, Issue 1-3, 2006, Pages 168-174

  Ishiwata, Yasuyoshi ^a   Itoga, Yoshie ^a   Yasuhara, Masato ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

(Rat); Epinephrine; Histamine; Hyperglycemia; Hypoglycemia; Levofloxacin

Indexed keywords

ADRENALIN; DIPHENHYDRAMINE; GLUCOSE; HISTAMINE; INSULIN; LEVOFLOXACIN;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL MEDULLA; ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD GLUCOSE; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; MALE; OFLOXACIN; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33750475980     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.081     Document Type: Article

References (28)

1. Aoki H., Okazaki O., Kurata T., Shintani S., Tachizawa H., and Hakusui H. The pharmacokinetics of DR-3355 (I): absorption, distribution and excretion after a single oral administration to rats. Xenobio. Metab. Dispos. 6 (1991) 113-123
2. Bertrand G., Gross R., Petit P., Loubatieres-Mariani M.M., and Ribes G. Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in rats. Eur. J. Pharmacol. 214 (1992) 159-163
3. Biggs W.S. Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients. J. Am. Board Fam. Pract. 16 (2003) 455-457
4. 1 receptor activation mediates the preferential release of adrenaline in the rat adrenal gland. Life Sci. 54 (1994) 631-640
5. Donaldson A.R., Vandiver J.R., and Finch C.K. Possible gatifloxacin-induced hyperglycemia. Ann. Pharmacother. 38 (2004) 602-605
6. Food and Drug Administration. Temafloxacin P92-16 (1998). http://www.fda.gov/bbs/topics/NEWS/NEW00279.html accessed 05/26/06
7. Friedrich L.V., and Dougherty R. Fatal hypoglycemia associated with levofloxacin. Pharmacotherapy 24 (2004) 1807-1812
8. Furuhata K., Hayakawa H., Soumi K., Arai H., Watanabe Y., and Narita H. Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration. Biol. Pharm. Bull. 21 (1998) 456-460
9. Haruhara N., Niwa H., Kitayama S., and Sakai N. Two cases of drug-induced hypoglycemic coma. J. Tomakomai City Gen. Hosp. 14 (2000) 45-48
10. Idesawa A., Izawa S., Koseki N., Machida M., Toriumi C., Yuasa R., Komuro M., Nagatsu Y., Ishida R., Ohkubo H., and Uchida H. Absorption, distribution and excretion of [14C] gatifloxacin after a single oral administration in rats. Jpn. J. Chemother. 47 Suppl. 2 (1999) 131-140
11. Ishiwata Y., Sanada Y., and Yasuhara M. Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats. Biol. Pharm. Bull. 29 (2006) 527-531
12. Kobayashi N., Tsuhako Y., Matsuyama R., Fujinaga M., and Nakamoto M. Hypoglycemic attacks in three patients with non-diabetic chronic renal failure on hemodialysis, with discussion of a patient who showed enoxacin-induced hypoglycemia. J. Jpn. Soc. Dial. Ther. 24 (1991) 951-956
13. Lawrence K.R., Adra M., and Keir C. Hypoglycemia-induced anoxic brain injury possibly associated with levofloxacin. J. Infect. 52 (2006) e177-e180
14. Linder J.A., Huang E.S., Steinman M.A., Gonzales R., and Stafford R.S. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am. J. Med. 118 (2005) 259-268
15. Maeda N., Tamagawa T., Niki I., Miura H., Ozaka K., Watanabe G., Nonogaki K., Uemura K., and Iguchi A. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br. J. Pharmacol. 117 (1996) 372-376
16. Mazzocchi G., Albertin G., Andreis P.G., Neri G., Malendowicz L.K., Champion H.C., Bahcelioglu M., Kadowitz P.J., and Nussdorfer G.G. Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland. Peptides 20 (1999) 1479-1487
17. Mitsui A., Nohta H., and Ohkura Y. High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. J. Chromatogr. 344 (1985) 61-70
18. Mori K., Maru C., and Takasuna K. Characterization of histamine release induced by fluoroquinolone antibacterial agents in-vivo and in-vitro. J. Pharm. Pharmacol. 52 (2000) 577-584
19. Owens R.C., and Ambrose P.G. Clinical use of the fluoroquinolones. Med. Clin. North Am. 84 (2000) 1447-1469
20. Package Insert. Tequin (gatifloxacin) (2002), Bristol-Myers Squibb., Princeton, US May
21. Package Insert. Avelox (moxifloxacin) (2005), Shionogi and Co., Ltd., Osaka, Japan December
22. Park-Wyllie L.Y., Juurlink D.N., Kopp A., Shah B.R., Stukel T.A., Stumpo C., Dresser L., Low D.E., and Mamdani M.M. Outpatient gatifloxacin therapy and dysglycemia in older adults. N. Engl. J. Med. 354 (2006) 1352-1361
23. +channels. Eur. J. Pharmacol. 497 (2004) 111-117
24. Suda M., Minami T., Aono H., Koh T., Hamada Y., and Yashiro M. Repeated hypoglycemia induced by lomefloxacin in chronic renal failure on hemodialysis. J. Kyoto City Hosp. 20 (2000) 41-46
25. Tack K.J., and Smith J.A. The safety profile of ofloxacin. Am. J. Med. 87 Suppl 6C (1989) 78S-81S
26. Van Bambeke F., Michot J.-M., Van Eldere J., and Tulkens P.M. Quinolones in 2005: an update. Clin. Microbiol. Infect. 11 (2005) 256-280
27. Yamada F., Inoue S., Saitoh T., Tanaka K., Satoh S., and Takamura Y. Glucoregulatory hormones in the immobilization stress-induced increase of plasma glucose in fasted and fed rats. Endocrinology 132 (1993) 2199-2205
28. Yoshizaki T. Effect of histamine, bradykinin and morphine on adrenaline release from rat adrenal gland. Jpn. J. Pharmacol. 23 (1973) 695-699